Birdwatch Note
2022-12-13 17:17:48 UTC - NOT_MISLEADING
“Ivermectin is not approved by the FDA for treatment of any viral infection.” Covid-19 Treatment Panel recommends against use of Ivermectin to treat covid except in clinical trials. https://www.covid19treatmentguidelines.nih.gov/therapies/miscellaneous-drugs/ivermectin/ NB: article I cited herein is written in 2022 unlike older study cited by another poster.
Written by 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1602152106219257858
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1602714417351004161
- noteId - 1602714417351004161
- participantId - 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10
- noteAuthorParticipantId -
- createdAtMillis - 1670951868748
- tweetId - 1602152106219257858
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- “Ivermectin is not approved by the FDA for treatment of any viral infection.” Covid-19 Treatment Panel recommends against use of Ivermectin to treat covid except in clinical trials. https://www.covid19treatmentguidelines.nih.gov/therapies/miscellaneous-drugs/ivermectin/ NB: article I cited herein is written in 2022 unlike older study cited by another poster.
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-12-13 17:17:48 UTC (1670951868748) |
1969-12-31 23:59:59 UTC (-1) |
2022-12-14 00:42:01 UTC (1670978521429) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 |
Note Ratings
rated at | rated by | |
2022-12-13 13:27:20 -0600 | 08956573BB2DC88E23E98EE7F3B4E96E8DD83B6A4D0EBCA73CA0D23CA67550C1 | Rating Details |
2022-12-13 13:50:23 -0600 | 099ED6B3483CCAAFF82E7DA324A5C9EBDE27115DEB1D8CF231520F8050170078 | Rating Details |
2022-12-13 20:21:31 -0600 | 0E3F6EB4AAF7233033251BACE0F0325D12DBDA5E1D67354D15807134017D9D96 | Rating Details |
2022-12-13 15:10:05 -0600 | 1072263077B70D8A33D125AAADF2A154557A9052308C4E6E527D9D17CDEF5F25 | Rating Details |
2022-12-13 11:46:37 -0600 | 1876C4C34E02274BC013B4C952618785674EA6A79DCAD1258AFC2751359E919E | Rating Details |
2022-12-13 20:11:52 -0600 | 2D4C83A96BA3B1DE6B629ABC08A9535751418C9761E70F4356D07687F99ABC1A | Rating Details |
2022-12-13 15:35:53 -0600 | 2DE4D1187BBD010232C9C95CF1EEE489DF83CAD1437EFF19EEEE62CF253E4D04 | Rating Details |
2022-12-13 19:04:33 -0600 | 2F5762DAD61B7FE245D64596F13CFB45FC1CF13004CDD4D28566E82B9EAC7354 | Rating Details |
2022-12-13 15:56:43 -0600 | 30B81CBCC14B55B4F31F55D77534B86E50EDE09EB06DC23EF7F8E69D61F4C8F9 | Rating Details |
2022-12-13 11:31:44 -0600 | 359A1C0F15FD54F6DD37B32E66B27769402C4C3CBB2D5D348D4EB13689EC6D5D | Rating Details |
2022-12-13 14:11:58 -0600 | 464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858 | Rating Details |
2022-12-13 13:23:38 -0600 | 570A7FD8B3BD968E3FAC5E5F85509AFCF802B8C7C769921A0E9A3F8086C800FF | Rating Details |
2022-12-13 14:26:19 -0600 | 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 | Rating Details |
2022-12-13 16:16:30 -0600 | 5FB9B68061EDA5E93528C6A547111421B76EBB9BCE4A9F6DF39B3E468E23455C | Rating Details |
2022-12-14 23:37:48 -0600 | 74FE5BD176B7E87747776B5997199F538C24A2466DD8E11FBA894F1D5DA66DCC | Rating Details |
2022-12-13 13:45:06 -0600 | 826BAE2151D204EBF3C24D63FE2658259725887D0734C98510B6EE2CE5172C02 | Rating Details |
2022-12-13 18:52:21 -0600 | 8413633E576A4D72316DCBCC16DD6B9362C24EB27398FCD7DBA90B344D27F010 | Rating Details |
2022-12-13 14:15:06 -0600 | 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E | Rating Details |
2022-12-13 12:44:50 -0600 | 9B927DB85E3A847E9DF9F137E5D3CA3637E8DBA7FEB2AF6A74703D4B4BD313ED | Rating Details |
2022-12-13 15:44:06 -0600 | A1810ED3E455FCD80A3E8386936936A3E2C10B957F08EB490632A28C78C37FFB | Rating Details |
2022-12-13 11:48:30 -0600 | A6706C9E1EE61DDA58847C2ACBE535C663BA583C6BB50C9326A09022B090B683 | Rating Details |
2022-12-13 17:24:15 -0600 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
2022-12-13 14:31:36 -0600 | ADD6D84E1F57E6163E655F2B417E4696E606ADB54DD1EDE679CED0D4F3222ABD | Rating Details |
2022-12-13 12:15:04 -0600 | E1EED97D6D2D5838BB61E20A0F4D02F98CE77030C7AA7F72AA66ACFB13C1A46D | Rating Details |
2022-12-13 16:03:23 -0600 | E343F092F0B44A6E8DEC7F3A16DFE90A5DA9F420CB1B9EDE2292D0B45E00C827 | Rating Details |
2022-12-14 08:40:21 -0600 | ECBA39C6F7FFF58DC3FAA41AE0F1FAD433AF9AC64A43D7BFBA9234CD1BF2B66C | Rating Details |
2022-12-14 01:04:08 -0600 | ED631A047550482645D6AF42E75C31CF2FE81AC9C6220396E1657D510F2C2F7C | Rating Details |
2022-12-13 15:55:30 -0600 | Rating Details | |
2022-12-13 16:40:48 -0600 | Rating Details | |
2022-12-13 19:15:27 -0600 | Rating Details | |
2022-12-13 18:53:58 -0600 | Rating Details | |
2022-12-14 08:43:44 -0600 | Rating Details | |
2022-12-13 11:48:30 -0600 | Rating Details | |
2022-12-13 20:11:52 -0600 | Rating Details | |
2022-12-14 01:04:08 -0600 | Rating Details | |
2022-12-13 16:16:30 -0600 | Rating Details | |
2022-12-14 23:37:48 -0600 | Rating Details | |
2022-12-13 14:15:06 -0600 | Rating Details | |
2022-12-13 12:44:50 -0600 | Rating Details | |
2022-12-13 18:52:21 -0600 | Rating Details | |
2022-12-13 15:44:06 -0600 | Rating Details | |
2022-12-13 17:24:15 -0600 | Rating Details | |
2022-12-13 15:55:30 -0600 | Rating Details | |
2022-12-13 16:03:23 -0600 | Rating Details | |
2022-12-13 11:31:44 -0600 | Rating Details | |
2022-12-13 13:45:06 -0600 | Rating Details | |
2022-12-13 14:31:36 -0600 | Rating Details | |
2022-12-13 13:27:20 -0600 | Rating Details | |
2022-12-13 11:46:37 -0600 | Rating Details | |
2022-12-13 16:40:48 -0600 | Rating Details | |
2022-12-13 20:21:31 -0600 | Rating Details | |
2022-12-13 14:11:58 -0600 | Rating Details | |
2022-12-13 12:15:04 -0600 | Rating Details | |
2022-12-13 13:50:23 -0600 | Rating Details | |
2022-12-13 13:23:38 -0600 | Rating Details | |
2022-12-13 19:15:27 -0600 | Rating Details | |
2022-12-13 15:35:53 -0600 | Rating Details | |
2022-12-13 18:53:58 -0600 | Rating Details | |
2022-12-13 14:26:19 -0600 | Rating Details | |
2022-12-13 15:56:43 -0600 | Rating Details | |
2022-12-13 15:10:05 -0600 | Rating Details | |
2022-12-14 08:43:44 -0600 | Rating Details | |
2022-12-13 19:04:33 -0600 | Rating Details | |
2022-12-14 08:40:21 -0600 | Rating Details |